Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty rats

Atherosclerosis

Volumn 184, Issue 2, 2006, Pages 283-289

  Desouza, Cyrus V ^a,b   Gerety, Moira ^a   Hamel, Frederick G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Hyperinsulinemia; Insulin resistance; Neointimal hyperplasia; Type 2 diabetes; Vascular endothelial growth factor; Vascular injury

Indexed keywords

INSULIN; VASCULOTROPIN;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS;

ANIMALS; BLOOD GLUCOSE; CAROTID ARTERIES; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; HYPERPLASIA; INSULIN RESISTANCE; OBESITY; RADIOIMMUNOASSAY; RATS; RATS, ZUCKER; TUNICA INTIMA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 30044431792     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.04.015     Document Type: Article

References (53)

1. J.B. Meigs Epidemiology of the metabolic syndrome Am J Manage Care 8 2002 S283 S292 quiz S293-286
2. M. Pyorala, H. Miettinen, P. Halonen, M. Laakso, and K. Pyorala Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study Arterioscler Thromb Vasc Biol 20 2000 538 544
3. S.H. Golden, A.R. Folsom, and J. Coresh Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study Diabetes 51 2002 3069 3076
4. S.M. Haffner, L. Mykkanen, A. Festa, J.P. Burke, and M.P. Stern Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state Circulation 101 2000 975 980
5. B. Hedblad, P. Nilsson, G. Engstrom, G. Berglund, and L. Janzon Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death Diab Med 19 2002 470 475
6. A. Kareinen, L. Viitanen, P. Halonen, S. Lehto, and M. Laakso Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease Arterioscler Thromb Vasc Biol 21 2001 1346 1352
7. A. Onat, K. Ceyhan, and V. Sansoy Fasting insulin levels independently associated with coronary heart disease in non-diabetic Turkish men and women Int J Cardiol 86 2002 61
8. L.E. Wagenknecht, R.B. D'Agostino Jr., S.M. Haffner, P.J. Savage, and M. Rewers Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the insulin resistance atherosclerosis study Diabetes Care 21 1998 1812 1818
9. T. Takagi, K. Yoshida, and T. Akasaka Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study J Am Coll Cardiol 36 2000 731 738
10. C. Indolfi, D. Torella, and C. Coppola Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture Am J Physiol Heart Circ Physiol 283 2002 H760 H767
11. A.W. Clowes, M.M. Clowes, and M.A. Reidy Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels Lab Invest 54 1986 295 303
12. S.H. Park, S.P. Marso, and Z. Zhou Neointimal hyperplasia after arterial injury is increased in a rat model of non-insulin-dependent diabetes mellitus Circulation 104 2001 815 819
13. C.V. Desouza, S.N. Murthy, and J. Diez Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats J Cardiovasc Pharmacol Ther 8 2003 297 305
14. E. Chou, I. Suzuma, and K.J. Way Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue Circulation 105 2002 373 379
15. F.L. Celletti, J.M. Waugh, and P.G. Amabile Inhibition of vascular endothelial growth factor-mediated neointima progression with angiostatin or paclitaxel J Vasc Interv Radiol 13 2002 703 707
16. V. Lindner, and M.A. Reidy Expression of VEGF receptors in arteries after endothelial injury and lack of increased endothelial regrowth in response to VEGF Arterioscler Thromb Vasc Biol 16 1996 1399 1405
17. E. Papalambros, F. Sigala, and S. Georgopoulos Vascular endothelial growth factor and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with plaque destabilization via neovascularization Cerebrovasc Dis 18 2004 160 165
18. M. Laitinen, and S. Yla-Herttuala Vascular gene transfer for the treatment of restenosis and atherosclerosis Curr Opin Lipidol 9 1998 465 469
19. N.K. Schiller, and D.B. McNamara Balloon catheter vascular injury of the alloxan-induced diabetic rabbit: the role of insulin-like growth factor-1 Mol Cell Biochem 202 1999 159 167
20. K. Matsumoto, R. Morishita, and A. Moriguchi Inhibition of neointima by angiotensin-converting enzyme inhibitor in porcine coronary artery balloon-injury model Hypertension 37 2001 270 274
21. Q. Pu, E. Wiel, and D. Corseaux Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock Crit Care Med 29 2001 1181 1188
22. N.K. Schiller, A.M. Timothy, and I.L. Chen Endothelial cell regrowth and morphology after balloon catheter injury of alloxan-induced diabetic rabbits Am J Physiol 277 1999 H740 H748
23. T. Burchardt, M. Burchardt, and J. Karden Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat J Urol 164 2000 1807 1811
24. Y. Asakura, M. Suzuki, and H. Nonogi Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM) J Cardiovasc Risk 5 1998 331 334
25. T. Przewlocki, P. Pieniazek, and W. Ryniewicz Long-term outcome of coronary balloon angioplasty in diabetic patients Int J Cardiol 76 2000 7 16
26. Y. Rozenman, D. Sapoznikov, and M.S. Gotsman Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus Clin Cardiol 23 2000 890 894
27. C. Indolfi, D. Torella, and L. Cavuto Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats Circulation 103 2001 2980 2986
28. N. Kwak, N. Okamoto, J.M. Wood, and P.A. Campochiaro VEGF is major stimulator in model of choroidal neovascularization Invest Ophthalmol Vis Sci 41 2000 3158 3164
29. J. Baffi, G. Byrnes, C.C. Chan, and K.G. Csaky Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor Invest Ophthalmol Vis Sci 41 2000 3582 3589
30. M.J. Yu, W.Y. Shen, and M.C. Lai The role of vascular endothelial growth factor (VEGF) in abnormal vascular changes in the adult rat eye Growth Factors 17 2000 301 312
31. H.E. Grossniklaus, J.X. Ling, and T.M. Wallace Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization Mol Vis 8 2002 119 126
32. Z. Wang, M.R. Castresana, and W.H. Newman Reactive oxygen and NF-kappaB in VEGF-induced migration of human vascular smooth muscle cells Biochem Biophys Res Commun 285 2001 669 674
33. J. Dulak, A. Jozkowicz, and W. Dichtl Vascular endothelial growth factor synthesis in vascular smooth muscle cells is enhanced by 7-ketocholesterol and lysophosphatidylcholine independently of their effect on nitric oxide generation Atherosclerosis 159 2001 325 332
34. T. Asahara, D. Chen, and Y. Tsurumi Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer Circulation 94 1996 3291 3302
35. S. Romano Di Peppe, A. Mangoni, and G. Zambruno Adenovirus-mediated VEGF (165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice Gene Ther 9 2002 1271 1277
36. P. Concina, S. Sordello, and M.A. Barbacanne The mitogenic effect of 17 beta-estradiol on in vitro endothelial cell proliferation and on in vivo reendothelialization are both dependent on vascular endothelial growth factor J Vasc Res 37 2000 202 208
37. P. Visweswaran, A.D. Johnson, and C.L. Tock Stimulation of growth and migration of vascular endothelial cells by vascular endothelial growth factor transduced smooth muscle cells in co-culture ASAIO J 43 1997 M753 M758
38. C. Miele, J.J. Rochford, N. Filippa, S. Giorgetti-Peraldi, and E. Van Obberghen Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways J Biol Chem 275 2000 21695 21702
39. G. Doronzo, I. Russo, and L. Mattiello Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance Eur J Clin Invest 34 2004 664 673
40. Z.Y. Jiang, Z. He, and B.L. King Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis J Biol Chem 278 2003 31964 31971
41. M.C. Blendea, D. Jacobs, and C.S. Stump Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression Am J Physiol Endocrinol Metab 288 2005 E353 E359
42. M. Furuhashi, N. Ura, and H. Takizawa Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity J Hypertens 22 2004 1977 1982
43. T. Nishibe, K. Miyazaki, and F. Kudo Induction of angiotensin converting enzyme in neointima after intravascular stent placement Int Angiol 21 2002 250 255
44. J.E. Toblli, G. Cao, G. DeRosa, F. Di Gennaro, and P. Forcada Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats Am J Hypertens 17 2004 172 180
45. T. Imanishi, T. Hano, and I. Nishio Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells Hypertens Res 27 2004 101 108
46. Q. Zhao, M. Ishibashi, and K. Hiasa Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling Hypertension 44 2004 264 270
47. S. Kim, Y. Izumi, and Y. Izumiya Beneficial effects of combined blockade of ACE and AT1 receptor on intimal hyperplasia in balloon-injured rat artery Arterioscler Thromb Vasc Biol 22 2002 1299 1304
48. A.J. Scheen Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system Drugs 64 2004 2537 2565
49. M.S. Bitar, S. Wahid, and S. Mustafa Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes Eur J Pharmacol 511 2005 53 64
50. A.E. Caballero Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes Curr Diab Rep 4 2004 237 246
51. S.H. Torres, J.B. De Sanctis, M. de L Briceno, N. Hernandez, and H.J. Finol Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients J Endocrinol 181 2004 419 427
52. A. Jozkowicz, J.P. Cooke, and I. Guevara Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF Cardiovasc Res 51 2001 773 783
53. J. Dulak, and A. Jozkowicz Regulation of vascular endothelial growth factor synthesis by nitric oxide: facts and controversies Antioxid Redox Signal 5 2003 123 132